We are live on
!
Find out more
NCM
Narwhal Capital Management Portfolio holdings
AUM
$1.45B
Turnover
15.82%
1-Year Est. Return
28.39%
This Fund
S&P 500
This Quarter
Est. Return
+10.15%
1 Year Est. Return
+28.39%
3 Year Est. Return
+93.85%
5 Year Est. Return
+119.75%
10 Year Est. Return
+391.36%
AUM
$752M
AUM Growth
+$61.4M
(+8.9%)
Cap. Flow
+$2.53M
Cap. Flow
% of AUM
0.34%
Top 10 Holdings %
Top 10 Hldgs %
35.98%
Holding
169
New
16
Increased
54
Reduced
64
Closed
8
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
5.3
years
Top 20 Avg Time Held Equity + Options
4.3
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
5.3
years
Top 20 Avg Time Held Equity only
4.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$3.1M |
| 2 |
Philip Morris
PM
|
+$2.11M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$2.11M |
| 4 |
Entegris
ENTG
|
+$1.89M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$1.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.72M |
| 2 |
Adobe
ADBE
|
+$2.37M |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.94M |
| 4 |
Deere & Co
DE
|
+$1.89M |
| 5 |
Walt Disney
DIS
|
+$1.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 19.55% |
| 2 | Technology | 16.8% |
| 3 | Healthcare | 12.55% |
| 4 | Financials | 9.82% |
| 5 | Consumer Staples | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
iShares Core S&P 500 ETF
IVV
$884B
| $49.4M | 6.57% |
128,530
+2,059
| +2% | +$795K |
2013 Q2
38 quarters
|
|
2
Apple
AAPL
$5.02T
| $38M | 5.05% |
292,260
-3,616
| -1% | -$517K |
2013 Q2
38 quarters
|
|
3
Microsoft
MSFT
$3.92T
| $37.9M | 5.04% |
158,157
-1,105
| -0.7% | -$265K |
2013 Q2
38 quarters
|
|
4
Alphabet (Google) Class C
GOOG
$4.15T
| $25.1M | 3.33% |
282,554
-3,861
| -1% | -$368K |
2014 Q2
34 quarters
|
|
5
Vulcan Materials
VMC
$33.4B
| $23.9M | 3.18% |
136,471
-6,159
| -4% | -$1.05M |
2013 Q2
38 quarters
|
|
6
iShares Gold Trust
IAU
$61.7B
| $23.4M | 3.12% |
677,768
-165
| -0% | -$5.42K |
2019 Q4
12 quarters
|
|
7
UnitedHealth
UNH
$361B
| $22.4M | 2.98% |
42,210
+707
| +2% | +$375K |
2013 Q2
38 quarters
|
|
8
JPMorgan Chase
JPM
$906B
| $18.8M | 2.5% |
140,433
+2,152
| +2% | +$273K |
2013 Q2
38 quarters
|
|
9
Home Depot
HD
$311B
| $16.3M | 2.17% |
51,562
+891
| +2% | +$271K |
2013 Q2
38 quarters
|
|
10
Johnson & Johnson
JNJ
$617B
| $15.3M | 2.04% |
86,752
+2,168
| +3% | +$374K |
2013 Q2
38 quarters
|
|
11
Amazon
AMZN
$2.73T
| $14.9M | 1.98% |
177,050
-3,328
| -2% | -$329K |
2013 Q2
38 quarters
|
|
12
Blackrock
BLK
$176B
| $13.9M | 1.85% |
19,588
-1,591
| -8% | -$1.06M |
2013 Q2
38 quarters
|
|
13
Procter & Gamble
PG
$369B
| $13.8M | 1.83% |
90,917
-2,869
| -3% | -$402K |
2013 Q2
38 quarters
|
|
14
Cisco
CSCO
$426B
| $13.4M | 1.78% |
281,590
+20,324
| +8% | +$925K |
2013 Q2
38 quarters
|
|
15
iShares S&P 500 Value ETF
IVE
$49.9B
| $12.7M | 1.69% |
87,830
+1,945
| +2% | +$278K |
2016 Q1
27 quarters
|
|
16
American Express
AXP
$214B
| $11.8M | 1.57% |
79,813
-2,362
| -3% | -$350K |
2014 Q4
32 quarters
|
|
|
17
RTX Corp
RTX
$257B
| $11.5M | 1.53% |
114,198
+32,922
| +41% | +$3.1M |
2013 Q2
38 quarters
|
|
18
Goldman Sachs
GS
$259B
| $11.5M | 1.53% |
33,559
+2,639
| +9% | +$919K |
2013 Q2
38 quarters
|
|
19
BlackRock Municipal 2030 Target Term Trust
BTT
$1.4B
| $11.3M | 1.51% |
531,990
-1,318
| -0.2% | -$27.7K |
2014 Q1
35 quarters
|
|
|
20
Pfizer
PFE
$169B
| $11.3M | 1.5% |
219,616
-56,636
| -21% | -$2.72M |
2013 Q2
38 quarters
|
|
21
Northrop Grumman
NOC
$72.5B
| $11M | 1.46% |
20,155
-735
| -4% | -$383K |
2013 Q2
38 quarters
|
|
22
NextEra Energy
NEE
$167B
| $11M | 1.46% |
131,533
+7,348
| +6% | +$594K |
2013 Q2
38 quarters
|
|
23
PepsiCo
PEP
$178B
| $10.3M | 1.37% |
56,918
+3,301
| +6% | +$589K |
2013 Q2
38 quarters
|
|
24
HCA Healthcare
HCA
$100B
| $9.93M | 1.32% |
41,390
+1,814
| +5% | +$406K |
2013 Q4
36 quarters
|
|
25
ExxonMobil
XOM
$725B
| $9.64M | 1.28% |
87,433
+3,956
| +5% | +$424K |
2013 Q2
38 quarters
|
|
Similar funds
NP
BFMH
WIM
SS
DN
SWM
VV
CTC
Narwhal Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Narwhal Capital Management held 169 positions worth $752M, up 8.9% from $691M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Narwhal Capital Management's Q4 2022 filing shows 16 new, 54 increased, 64 reduced and 8 closed positions. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 15,900 shares worth $2.16M. The largest sale was Pfizer, an estimated $2.72M.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
- Narwhal Capital Management's largest Q4 2022 buy was State Street Health Care Select Sector SPDR ETF: 15,900 shares worth $2.16M.
- Narwhal Capital Management added most to RTX Corp in Q4 2022, an estimated $3.1M increase.
- Narwhal Capital Management's biggest Q4 2022 reduction was Pfizer, cutting an estimated $2.72M.
- Narwhal Capital Management fully exited ProShares UltraPro Short S&P 500 in Q4 2022, selling an estimated $390K.
- Narwhal Capital Management's ten largest holdings make up 36% of its $752M portfolio in Q4 2022.
- Narwhal Capital Management opened 16 new positions and closed 8 in Q4 2022.
- Narwhal Capital Management's portfolio value rose 8.9% quarter-over-quarter to $752M.
Based on Narwhal Capital Management's 13F filing for Q4 2022, filed 31 Jan 2023.